icon-    folder.gif   Conference Reports for NATAP  
 
  IAS 2019: Conference on HIV Pathogenesis
Treatment and Prevention
Mexico City
July 21-24 2019
Back grey_arrow_rt.gif
 
 
 
A Subgroup Analysis of the Week 96 Efficacy and Safety Results Evaluating Fostemsavir in Heavily Treatment-Experienced HIV-1 Infected Participants in the Phase 3 BRIGHTE Study: Results From The Randomized Cohort
 
 
  Reported by Jules Levin
10th IAS Conference on HIV Science (IAS 2019), 21-24 July 2019, Mexico City, Mexico

0724191

0724192

0724193

0724194

0724195

0724196

0724197

0724198

0724199